<DOC>
	<DOCNO>NCT02043366</DOCNO>
	<brief_summary>Purpose : To explore compare antihyperalgesic effect butorphanol , flurbiprofen axetil , combination receive anesthesia induction . To evaluate examine incidence adverse effect purpose select optimum dose .</brief_summary>
	<brief_title>Effect Butorphanol Combined With Flurbiprofen Axetil Preventing Hyperalgesia Induced Remifentanil Patients</brief_title>
	<detailed_description>There dramatically increase number evidence administration potent , ultra-short-acting opioid remifentanil seem cause opioid-induced hyperalgesia ( OIH ) frequently predictably compare others , likely due rapid onset offset . Therefore , prophylaxis remifentanil induce hyperalgesia indispensable postoperative comfort satisfaction . There deny fact OIH related central glutaminergic system N-methyl-d-aspartate ( NMDA ) receptor-activation induced central sensitization . Prostaglandins promote glutamate release astrocytes spinal cord dorsal horn subsequent activation NMDA receptor , flurbiprofen axetil , non-steroidal anti-inflammatory drug ( NSAIDs ) , functionally antagonize NMDA receptor activation via inhibition prostaglandin , also target drug gather site inflammation , thus greatly enhance analgesic effect . While butorphanol spinal analgesic sedative function predominantly central κ-receptor agonist activation , advantage butorphanol include side effect , low addiction potential , low toxicity account partial agonist-antagonist activity μ-receptor . Moreover , antihyperalgesic activity κ opioids site inflammation report various acute pain model . The follow study carry evaluate whether butorphanol combine flurbiprofen axetil safely effectively apply prevent postoperative hyperalgesia induce remifentanil patient undergo low abdominal surgery .</detailed_description>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Butorphanol</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Flurbiprofen</mesh_term>
	<mesh_term>Flurbiprofen axetil</mesh_term>
	<criteria>1 . Subject schedule undergo low abdominal surgery short general anesthesia le 2 hour 2 . Subject 's American Society Anesthesiologists physical status III . 3 . The subject 's parent/legally authorized guardian give write informed consent participate . 1 . Subject diagnosis renal liver failure . 2 . Subject diagnosis Insulin dependent diabetes . 3 . Subject allergy contraindication butorphanol NSAIDs . 4 . Subject history chronic pain , history alcohol opioid abuse , preexist therapy opioids , intake analgesic drug within 48 hour surgery . 5 . Subject contraindication use patientcontrolled analgesia ( PCA ) . 6 . Subject pregnant breastfeeding . 7 . Subject obese ( body mass index &gt; 30kg/m^2 ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Remifentanil</keyword>
	<keyword>Opioid-induced hyperalgesia</keyword>
	<keyword>Postoperative pain</keyword>
	<keyword>Pain Intensity</keyword>
</DOC>